Siga Technologies (SIGA) Non-Current Assets (2010 - 2025)
Siga Technologies' (SIGA) quarterly Non-Current Assets came in at $6.6 million in Q4 2025, down 50.27% on a YoY basis from $13.3 million in Q4 2024, and up 71.36% quarter-over-quarter from $3.9 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Non-Current Assets (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Non-Current Assets for 16 consecutive years, with $6.6 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Assets fell 50.27% year-over-year to $6.6 million; the trailing twelve-month figure through Dec 2025 stood at $30.0 million (down 49.42% YoY), and the FY2025 full-year result was $6.6 million, down 50.27% from the prior year.
- Non-Current Assets climbed to $6.6 million in Q4 2025 per SIGA's latest filing, from $3.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $16.2 million in Q2 2024 and bottomed at $3.9 million in Q3 2025.
- Historically, Non-Current Assets has averaged $9.8 million across 5 years, with a median of $8.3 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets jumped 93.94% in 2023, then plunged 73.7% in 2025.
- Over 5 years, Non-Current Assets stood at $6.0 million in 2021, then soared by 54.84% to $9.2 million in 2022, then jumped by 66.08% to $15.4 million in 2023, then fell by 13.47% to $13.3 million in 2024, then tumbled by 50.27% to $6.6 million in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $6.6 million, $3.9 million, and $6.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 159.77 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 294.93 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1.85 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 3.74 Bn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 6.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.61 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 13.45 Mn |
| Dec 31, 2024 | 13.29 Mn |
| Sep 30, 2024 | 14.67 Mn |
| Jun 30, 2024 | 16.18 Mn |
| Mar 31, 2024 | 15.25 Mn |
| Dec 31, 2023 | 15.36 Mn |
| Sep 30, 2023 | 12.41 Mn |
| Jun 30, 2023 | 12.21 Mn |
| Mar 31, 2023 | 11.39 Mn |
| Dec 31, 2022 | 9.25 Mn |
| Sep 30, 2022 | 7.32 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | 7.44 Mn |
| Dec 31, 2021 | 5.97 Mn |
| Sep 30, 2021 | 6.63 Mn |
| Jun 30, 2021 | 6.62 Mn |
| Mar 31, 2021 | 5.88 Mn |